Synthesis, cytotoxic evaluation and in silico pharmacokinetic prediction of some benzo[a]phenazine-5-sulfonic acid derivatives

Medicinal Chemistry

Volumn 5, Issue 6, 2009, Pages 549-557

  Moorthy, N S Hari Narayana ^a   Karthikeyan, C ^a   Trivedi, Piyush ^a  

^a UNIVERSITY INSTITUTE OF TECHNOLOGY   (India)

Author keywords

Benzo a phenazine 5 sulfonic acid; Cytotoxic activity; Human leukemia; In silico pharmacokinetic

Indexed keywords

BENZO[A]PHENAZINE 5 SULFONIC ACID DERIVATIVE; CISPLATIN; INTERCALATING AGENT; UNCLASSIFIED DRUG;

ARTICLE; CELL STRAIN HL 60; COMPUTER MODEL; CONTROLLED STUDY; DNA BINDING; DRUG CYTOTOXICITY; DRUG METABOLISM; DRUG SOLUBILITY; DRUG SYNTHESIS; HUMAN; HUMAN CELL; IC 50; MELTING POINT; MOLECULAR WEIGHT; PRIORITY JOURNAL; QUANTITATIVE STRUCTURE ACTIVITY RELATION;

ANIMALS; ANTINEOPLASTIC AGENTS; CATTLE; COMPUTATIONAL BIOLOGY; DNA; HL-60 CELLS; HUMANS; INTERCALATING AGENTS; NUCLEIC ACID DENATURATION; STRUCTURE-ACTIVITY RELATIONSHIP; SULFONIC ACIDS;

EID: 75749133254     PISSN: 15734064     EISSN: None     Source Type: Journal    
DOI: 10.2174/157340609790170533     Document Type: Article

References (21)

1. http://www.who.int/cancer/en/
2. Merlo, L.M.; Pepper, J.W.; Reid, B.J.; Maley, C.C. Cancer as an evolutionary and ecological process. Nat. Rev. Cancer, 2006, 6(12), 924-35.
3. Cho, R.W.; Clarke, M.F. Recent advances in cancer stem cells. Curr. Opin. Genet. Dev., 2008, 18(1), 48-53.
4. Desai, P.B. Cancer controls efforts in the Indian subcontinent. Jpn. J. Clin. Oncol., 2002, 32, 13-16.
5. Gombar, V.K.; Silver, I.S.; Zhao, Z. Angiogenesis in cancer and other diseases. Curr. Top. Med. Chem., 2003, 3(11), 1205-25.
6. Ilaria, M.; Marcello, I.; Alessio, C.; Marilene, S.; Niccolo, C.; Anna, M.B. Development of QSAR models for predicting hepatocarcinogenic toxicity of chemicals. Eur. J. Med. Chem., 2009, 44(9), 3658-64.
7. Oprea, T.I. Virtual screening in lead discovery: A viewpoint. Molecules, 2002, 7, 51-62.
8. Denny, W.A. Chemotherapeutic effects of acridine derivatives. Med. Chem. Rev., 2004, 1, 257-66.
9. Wang, J.C. DNA topoisomerases. Annu. Rev. Biochem., 1996, 65, 635-91.
10. Jelic, S.; Nikolic-Tomasevic, Z.; Kovcin, V.; Milanovic, N.; Tomasevic, Z.; Jovanivic, V.; Vlajic, M. DNA-targeted 1,2,4-benzotriazine 1,4-dioxides: potent analogues of the hypoxiaselective cytotoxin tirapazamine. J. Chemother., 1997, 9(5), 364-70.
11. Ippolito, A.; Paolo, P.; Ameila, M.; Barbara, G.; Mantio, P.; Ernesto, M.; Coletta, N.; Sante, M. Design, synthesis and biological properties of new bis(acridine-4-carboxamides as anticancer agents. J. Med. Chem., 2003, 46, 3109-15.
12. Lu, W.; Harry, L.P.; Jane, J.; Martin, K.; Otto, P. Influence of polyamine architecture on the transport and topoisomerase II inhibitory properties of polyamine DNA intercalator conjugates. J. Med. Chem., 2001, 44, 3682-91.
13. Vicker, N.; Luke, B.; Irina, B.C.; Rory, D.; Adrian, J.F.; David, J.H.; Timothy, C.H.; Warren, M.; John, M.; Sukjit, S.; Shouming, W.; Stephen, P.W.; Peter, A.C.; Wendey, D.; Chris, L.; Prakash, M.; Alistair, J.S.; William, A.D. Novel, angular, benzophenazines: Dual topoisomerase I and topoisomerase II inhibitors as potential anticancer agents. J. Med. Chem., 2002, 45, 721-39.
14. McDonald, L.A.; Eldredge, G.S.; Barrows, L.R.; Ireland, C.M. Inhibition of topoisomerase II-mediated DNA cleavage by pyridoacridine alkaloids from a Cystodytes sp. Ascidian: A mechanism for the apparent intercalator-induced inhibition of topoisomerase II. J. Med. Chem., 1994, 37, 3819-27.
15. Pallas 3.1.1.2, ADME-Tox software, CompuDrug International Inc., U.S.A., 2000.
16. Martin, Y.C.; Kutter, E.; Austel, V. The medicinal chemist's approach, in modern Drug Research, Path to Better and safer Drugs, Marcel Dekker, Inc., New York, 1989.
17. Smith, D.A. Design of drugs through a consideration of drug metabolism and pharmacokinetics. Eur. J. Drug. Metab. Pharm., 1994, 3, 193-99.
18. Skehan, P.; Storeng, R.; Scudiero, D.; Monks, A.; Mcmahon, J.; Vistica, D.; Warren, J.T.; Bokesch, H.; Kenney, S.; Boyd, M.R. New colorimetric cytotoxicity assay for anti-cancer drug screening. J. Natl. Cancer Inst., 1990, 82, 1107-12.
19. Patel, D.J.; Shapiro, L. Nuclear magnetic resonance and distance geometry studies of DNA structures in solution. Annu. Rev. Biophys. Chem., 1987, 16, 423-54.
20. Harris, T.M.; Stone, M.P.; Harris, C.M. Applications of NMR spectroscopy to studies of reactive intermediates and their interactions with nucleic acids. Chem. Res. Toxicol., 1988, 1(2), 79-96.
21. Hsiang, Y.H.; Jiang, T.B.; Lieu, L.F. Topoisomerase II-mediated DNA cleavage by amonafide and its structural analogs. Mol. Pharmacol., 1989, 36(3), 371-376.